Subcellular distribution of FTY720 and FTY720-phosphate in immune cells – another aspect of Fingolimod action relevant for therapeutic application

References

Alemany, R., van Koppen, C.J., Danneberg, K., Ter Braak, M., and Meyer Zu Heringdorf, D. (2007). Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch. Pharmacol. 374, 413–428.Suche in Google Scholar

Anada, Y., Igarashi, Y., and Kihara, A. (2007). The immunomodulator FTY720 is phosphorylated and released from platelets. Eur. J. Pharmacol. 568, 106–111.10.1016/j.ejphar.2007.04.053Suche in Google Scholar PubMed

Arlt, O., Schwiebs, A., Japtok, L., Ruger, K., Katzy, E., Kleuser, B., and Radeke, H.H. (2014). Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo. Cell. Physiol. Biochem. 34, 27–44.10.1159/000362982Suche in Google Scholar PubMed

Bandhuvula, P., Tam, Y.Y., Oskouian, B., and Saba, J.D. (2005). The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280, 33697–33700.10.1074/jbc.C500294200Suche in Google Scholar PubMed

Blaho, V.A. and Hla, T. (2014). An update on the biology of sphingosine 1-phosphate receptors. J. Lipid Res. 55, 1596–1608.10.1194/jlr.R046300Suche in Google Scholar PubMed PubMed Central

Blom, T., Back, N., Mutka, A.L., Bittman, R., Li, Z., de Lera, A., Kovanen, P.T., Diczfalusy, U., and Ikonen, E. (2010). FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. Circ. Res. 106, 720–729.10.1161/CIRCRESAHA.109.204396Suche in Google Scholar PubMed PubMed Central

Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., and Burtin, P. (2010). Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9, 883–897.10.1038/nrd3248Suche in Google Scholar PubMed

Bryan, L., Kordula, T., Spiegel, S., and Milstien, S. (2008). Regulation and functions of sphingosine kinases in the brain. Biochim. Biophys. Acta 1781, 459–466.10.1016/j.bbalip.2008.04.008Suche in Google Scholar PubMed PubMed Central

Cartwright, T.A., Campos, C.R., Cannon, R.E., and Miller, D.S. (2013). Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. J. Cereb. Blood Flow Metab. 33, 381–388.10.1038/jcbfm.2012.174Suche in Google Scholar PubMed PubMed Central

Cinamon, G., Zachariah, M.A., Lam, O.M., Foss, F.W., and Cyster, J.G. (2008). Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9, 54–62.10.1038/ni1542Suche in Google Scholar PubMed PubMed Central

Ferreirós, N., Labocha, S., Schröder, M., Radeke, H.H., and Geisslinger, G. (2012). LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 887–888, 122–127.10.1016/j.jchromb.2012.01.023Suche in Google Scholar PubMed

Fukuhara, S., Simmons, S., Kawamura, S., Inoue, A., Orba, Y., Tokudome, T., Sunden, Y., Arai, Y., Moriwaki, K., Ishida, J., et al. (2012). The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122, 1416–1426.10.1172/JCI60746Suche in Google Scholar PubMed PubMed Central

Hait, N.C., Allegood, J., Maceyka, M., Strub, G.M., Harikumar, K.B., Singh, S.K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S. et al. (2009). Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254–1257.10.1126/science.1176709Suche in Google Scholar PubMed PubMed Central

Hisano, Y., Kobayashi, N., Kawahara, A., Yamaguchi, A., and Nishi, T. (2011). The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J. Biol. Chem. 286, 1758–1766.10.1074/jbc.M110.171116Suche in Google Scholar PubMed PubMed Central

Honig, S.M., Fu, S., Mao, X., Yopp, A., Gunn, M.D., Randolph, G.J., and Bromberg, J.S. (2003). FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J. Clin. Invest. 111, 627–637.10.1172/JCI200316200Suche in Google Scholar

Huwiler, A. and Pfeilschifter, J. (2008). New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. Biochem. Pharmacol. 75, 1893–1900.10.1016/j.bcp.2007.12.018Suche in Google Scholar PubMed

Igarashi, N., Okada, T., Hayashi, S., Fujita, T., Jahangeer, S., and Nakamura, S. (2003). Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278, 46832–46839.10.1074/jbc.M306577200Suche in Google Scholar PubMed

Kappos, L., Radue, E.W., O’Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387–401.10.1056/NEJMoa0909494Suche in Google Scholar PubMed

Lim, K.G., Sun, C., Bittman, R., Pyne, N.J., and Pyne, S. (2011). (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells. Cell. Signal. 23, 1590–1595.10.1016/j.cellsig.2011.05.010Suche in Google Scholar PubMed PubMed Central

Limaye, V. (2008). The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology. Endothelium 15, 101–112.10.1080/10623320802125342Suche in Google Scholar PubMed

Liu, M., Seo, J., Allegood, J., Bi, X., Zhu, X., Boudyguina, E., Gebre, A.K., Avni, D., Shah, D., Sorci-Thomas, M.G. et al. (2014). Hepatic apolipoprotein M (ApoM) overexpression stimulates formation of larger ApoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. J. Biol. Chem. 289, 2801–2814.10.1074/jbc.M113.499913Suche in Google Scholar PubMed PubMed Central

Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.J., Card, D., Keohane, C., et al. (2002). Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346–349.10.1126/science.1070238Suche in Google Scholar

Matloubian, M., Lo, C.G., Cinamon, G., Lesneski, M.J., Xu, Y., Brinkmann, V., Allende, M.L., Proia, R.L., and Cyster, J.G. (2004). Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355–360.10.1038/nature02284Suche in Google Scholar

Moriue, T., Igarashi, J., Yoneda, K., Nakai, K., Kosaka, H. and Kubota, Y. (2008). Sphingosine 1-phosphate attenuates H₂O₂-induced apoptosis in endothelial cells. Biochem. Biophys. Res. Commun. 368, 852–857.10.1016/j.bbrc.2008.01.155Suche in Google Scholar

Neumann, S. and van Meer, G. (2008). Sphingolipid management by an orchestra of lipid transfer proteins. Biol. Chem. 389, 1349–1360.10.1515/BC.2008.154Suche in Google Scholar

Nishi, T., Kobayashi, N., Hisano, Y., Kawahara, A. and Yamaguchi, A. (2014). Molecular and physiological functions of sphingosine 1-phosphate transporters. Biochim. Biophys. Acta 1841, 759–765.10.1016/j.bbalip.2013.07.012Suche in Google Scholar

Oo, M.L., Chang, S.H., Thangada, S., Wu, M.T., Rezaul, K., Blaho, V., Hwang, S.I., Han, D.K., and Hla, T. (2011). Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice. J. Clin. Invest. 121, 2290–2300.10.1172/JCI45403Suche in Google Scholar

Oskeritzian, C.A., Alvarez, S.E., Hait, N.C., Price, M.M., Milstien, S., and Spiegel, S. (2008). Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood 111, 4193–4200.10.1182/blood-2007-09-115451Suche in Google Scholar

Paugh, S.W., Payne, S.G., Barbour, S.E., Milstien, S., and Spiegel, S. (2003). The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554, 189–193.10.1016/S0014-5793(03)01168-2Suche in Google Scholar

Payne, S.G., Oskeritzian, C.A., Griffiths, R., Subramanian, P., Barbour, S.E., Chalfant, C.E., Milstien, S., and Spiegel, S. (2007). The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood 109, 1077–1085.10.1182/blood-2006-03-011437Suche in Google Scholar PubMed PubMed Central

Price, M.M., Oskeritzian, C.A., Falanga, Y.T., Harikumar, K.B., Allegood, J.C., Alvarez, S.E., Conrad, D., Ryan, J.J., Milstien, S., and Spiegel, S. (2013). A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J. Allergy Clin. Immunol. 131, 501–511. e501.10.1016/j.jaci.2012.07.014Suche in Google Scholar PubMed PubMed Central

Qin, J., E. Berdyshev, Goya, J., Natarajan, V., and Dawson, G. (2010). Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis. J. Biol. Chem. 285, 14134–14143.10.1074/jbc.M109.076810Suche in Google Scholar PubMed PubMed Central

Rathmell, J.C., Farkash, E.A., Gao, W., and Thompson, C.B. (2001). IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167, 6869–6876.10.4049/jimmunol.167.12.6869Suche in Google Scholar PubMed

Saddoughi, S.A., Song, P., and Ogretmen, B. (2008). Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell. Biochem. 49, 413–440.10.1007/978-1-4020-8831-5_16Suche in Google Scholar PubMed PubMed Central

Saddoughi, S.A., Gencer, S., Peterson, Y.K., Ward, K.E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z.M., Thomas, R.J., Selvam, S.P., et al. (2013). Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol. Med. 5, 105–121.10.1002/emmm.201201283Suche in Google Scholar PubMed PubMed Central

Schwab, S.R., Pereira, J.P., Matloubian, M., Xu, Y., Huang, Y., and Cyster, J.G. (2005). Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735–1739.10.1126/science.1113640Suche in Google Scholar PubMed

Sensken, S.C., Bode, C., and Graler, M.H. (2009). Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J. Pharmacol. Exp. Ther. 328, 963–969.10.1124/jpet.108.148163Suche in Google Scholar PubMed

Simons, K. and van Meer, G. (1988). Lipid sorting in epithelial cells. Biochemistry 27, 6197–6202.10.1021/bi00417a001Suche in Google Scholar PubMed

Skoura, A. and Hla, T. (2009). Lysophospholipid receptors in vertebrate development, physiology, and pathology. J. Lipid Res. 50 (Suppl.), S293–298.10.1194/jlr.R800047-JLR200Suche in Google Scholar PubMed PubMed Central

Spiegel, S. and Milstien, S. (2011). The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11, 403–415.10.1038/nri2974Suche in Google Scholar PubMed PubMed Central

van Meer, G. and de Kroon, A.I. (2011). Lipid map of the mammalian cell. J. Cell Sci. 124, 5–8.10.1242/jcs.071233Suche in Google Scholar PubMed

von Andrian, U.H. and Mackay, C.R. (2000). T-cell function and migration. Two sides of the same coin. N. Engl. J. Med 343, 1020–1034.10.1056/NEJM200010053431407Suche in Google Scholar PubMed